1Crow RS.Peripheral neuritia in myolomatosis[J].Bri Med J,1956,2(7):802-802.
2Nakanishi T,Sobue I,Toyokura Y,et al.The Crow Fukase syndrome:a study of 102 cases in Japan[J].Neurology,1984,34(6):712-720.
3Bardwick PA,Zvaifler NJ,Gill GN,et al.Plasma cell dyscrasia with polyneuropathy,organomegaly,endocrinopathy,Mprotein,and skin changes:the POEMS syndrome:report on two cases and a review of the literature[J].Medicine(Baltimore),1980,59(4):311-322.
2Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome [J]. Blood, 2003, 101 (7) : 2496 - 2506.
3Kulkarni GB, Mahadevan A, Taly AB, et al. Clinicopathological profile of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome [J]. J Clin Neurosci, 2011, 18 (3) : 356 -360.
4Dursun B, Artac M, Varan HI, et al. An atypical case of POEMS syndrome with IgG kappa M protein and end stage renal failure [ J ]. Int Urol Nephrology, 2005, 37 (3): 581-585.
5Dispenzieri A. POEMS syndrome: 2011 update on diagnosis, risk - stratification, and management [ J]. Am J Hematol, 2011, 86 (7) : 591 - 601.
7Ozaki J, Okumura H, Iwamoto K, et al. Refractory crow - fukase syndrome (POEMS syndrome) successfully treated with high - dose melphalan followed by autologous peripheral blood stem cell transplantation [J]. Int J Hematol, 2004, 79 (1): 95-99.
8Dogan S, Beyazit Y, shorbagi A, et al. Gastrointestinal involvement in POEMS syndrome : a novel clinical manifestation [ J ]. Postgrad Med J, 2005, 81 (959): e12.
9Dispenzieri A. POEMS syndrome [ J ]. Hematology Am Soc Hematol Educ Program, 2005 : 360 - 367.
10Oehadian A, Prasetya D, Fadjari TH. POEMS syndrome: a rare case of monoclonal plasmaproliferative disorder [ J ]. Acta Med Indones, 2010, 42 (2): 100-103.
3DSouza A,Hayman SR,Buadi F,et al.ne utility of plasma vascular endothelial growth factor levels in the diagnosis and followup of patientswith POEMS syndrome[J].Blood,2011,118(17):4663-4665.
4Belec L,Authier FJ,Mohamed AS.Antibodies to human herpesvirus 8 in POEMS(polyneur,opathy,organomegaly,endocr inopathy,M protein,skin changes)syndrome with multicentric Castleman'sdisease[J].Clin Infect Dis,1999,28(3):678-679.
5Dispenzieri A,Gertz MA.Treatment of POEMS syndrome[J].Curt Treat Options Oncol,2004,5(3):249-257.
6Dispenzieri A.POEMS syndrome:2011 update on diagnosis,riskstratification,and management[J].Am J Hematol,2011,86(7):591–601.
7Dispenzieri A,Kyle RA,Lacy MQ.POEMS syndrome:definition and long-term outcome[J].Blood,2003,101(7):2496-2506.
8Kuwabara S,Hattori T,'Shimoo Y,et al.Long term melphalan·prednisolone chemotherapy for POEMs syndrome.J Neurol Neurosurg Psychiatry,1997,63(3):385-387.
9Nakamura Y,Sato Y,ho Y,et al.POEMS syndrome presenting w It h t r a n sie nt i m mu nog lobu l i n i sot y p e s w it ch i ng a f t e r successful treatment with autologous peripheral blood stem cell transplantation[J].Rinsho Ketsueki,2007,48(8):642-646.
10Kojima H,Katsuoka Y,Katsura Y,et al.Successful treatment of a patient with POEMS sy nd rome by tandem high-dose chemotherapy with autologous c D3:purged stem cell rogue[J].Int J Hematol,2006,84(2):182-185.
